Pentetrazol drug molecule. Computer model of Pentetrazol (PTZ), a potential drug candidate for Down's syndrome, formally used as a circulatory and res
Pentetrazol drug molecule. Computer model of Pentetrazol (PTZ), a potential drug candidate for Down's syndrome, formally used as a circulatory and respiratory stimulant under the trade name Metrazol. In February 2007 it was found that PTZ substantially improved learning and memory in mice with Down's syndrome symptoms. PTZ is a GABA antagonist, meaning it binds to receptor neurons and hence blocks the action of GABA, an inhibitory neurotransmitter. It is thought that people with Down's syndrome have too much GABA-related inhibition, making it difficult for them to process information and learn effectively. Atoms are colour-coded: nitrogen (yellow), carbon (pink) and hydrogen (white).
Size: 4200px × 3150px
Photo credit: © DR TIM EVANS/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: antagonist, artwork, atom, atoms, biochemical, biochemistry, biological, biology, central, chemical, chemistry, circulatory, cns, composition, compound, compounds, downs, drug, fill, filled, gaba, illustration, medical, medication, medicine, metrazol, model, molecular, molecule, molecules, nervous, neurological, neurology, pentamethylenetetrazol, pentetrazol, pentylenetetrazol, pharmaceutical, pharmaceutics, pharmacological, pharmacology, potential, ptz, respiratory, single, space, space-fill, space-filled, spacefill, spacefilled, stimulant, structure, syndrome, system, treatment
